文献速递新生儿儿童消化与营养儿童心血管与肾脏

单心室生理新生儿纯人乳饮食的随机试验

A Randomized Trial of an Exclusive Human Milk Diet in Neonates with Single Ventricle Physiology.
PubMed 文献 · J Pediatr · 2022-12-14

这项多中心随机单盲对照试验纳入107例7日龄内单心室生理足月新生儿,比较术后30天纯人乳饮食(人乳强化剂)与混合人乳牛乳饮食。纯人乳组体重增长中位数更高(12 vs 8 g/day,P=.03),坏死性小肠结肠炎发生率更低(3.6% vs 15.4%,P=.04),其他主要并发症、住院时长和死亡无差异。

要点

  • 单心室生理新生儿术后纯人乳饮食可改善短期体重增长。
  • 纯人乳饮食与坏死性小肠结肠炎风险降低相关(3.6% vs 15.4%)。
  • 其他主要并发症、手术并发症、住院时长和院内死亡两组相似。

核心结论

  • 单心室生理新生儿在stage 1手术姑息后接受纯人乳饮食,短期生长改善且坏死性小肠结肠炎风险降低。

研究设计与样本

  • 多中心、随机、单盲、对照试验,在美国10个中心纳入107例7日龄或以下单心室生理足月新生儿(纯人乳组55例,对照组52例)。

主要发现

  • 研究完成时体重增长速度中位数纯人乳组高于对照组(12 g/day [IQR, 5-18 g/day] vs 8 g/day [IQR, 0.4-14 g/day],P=.03)。
  • 其他生长指标两组相似。
  • 所有Bell分期坏死性小肠结肠炎对照组发生率高于纯人乳组(15.4% vs 3.6%,P=.04)。
  • 其他主要疾病、手术并发症、住院时长和院内死亡率两组相似。

关键数值与推荐

  • 干预组在术后开始喂养后30天内,肠内摄入达60 mL/kg/day时使用为人足月新生儿设计的人乳强化剂强化人乳。
  • 对照组在肠内摄入达100 mL/kg/day时使用标准配方奶强化。
  • 两组术前如喂养均接受人乳,并遵循围手术期喂养和肠外营养研究算法。

临床怎么用

  • 对于单心室生理新生儿,stage 1手术姑息后优先考虑纯人乳饮食可能改善短期体重增长并降低坏死性小肠结肠炎风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether weight gain velocity (g/kg/day) 30 days after the initiation of feeds after cardiac surgery and other clinical outcomes improve in infants with single ventricle physiology fed an exclusive human milk diet compared with a mixed human and bovine diet. STUDY DESIGN: In this multicenter, randomized, single blinded, controlled trial, term neonates 7 days of age or younger with single ventricle physiology and anticipated cardiac surgical palliation within 30 days of birth were enrolled at 10 US centers. Both groups received human milk if fed preoperatively. During the 30 days after feeds were started postoperatively, infants in the intervention group received human milk fortified once enteral intake reached 60 mL/kg/day with a human milk-based fortifier designed for term neonates. The control group received standard fortification with formula once enteral intake reached 100 mL/kg/day. Perioperative feeding and parenteral nutrition study algorithms were followed. RESULTS: We enrolled 107 neonates (exclusive human milk = 55, control = 52). Baseline demographics and characteristics were similar between the groups. The median weight gain velocity at study completion was higher in exclusive human milk vs control group (12 g/day [IQR, 5-18 g/day] vs 8 g/day [IQR, 0.4-14 g/day], respectively; P = .03). Other growth measures were similar between groups. Necrotizing enterocolitis of all Bell stages was higher in the control group (15.4 % vs 3.6%, respectively; P = .04). The incidence of other major morbidities, surgical complications, length of hospital stay, and hospital mortality were similar between the groups. CONCLUSIONS: Neonates with single ventricle physiology have improved short-term growth and decreased risk of NEC when receiving an exclusive human milk diet after stage 1 surgical palliation. TRIAL REGISTRATION: This trial is registered with ClinicalTrials.gov (www. CLINICALTRIALS: gov, Trial ID: NCT02860702).

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Blanco CL, Hair A, Justice LB, et al. A Randomized Trial of an Exclusive Human Milk Diet in Neonates with Single Ventricle Physiology. J Pediatr. 2022. PMID: 36528055. doi:10.1016/j.jpeds.2022.11.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。